Qualigen Therapeutics, Inc. (QLGN) DCF Valuation

Qualigen Therapeutics, Inc. (QLGN) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Qualigen Therapeutics, Inc. (QLGN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you're an investor or analyst, this (QLGN) DCF Calculator is your essential tool for accurate valuation. Featuring real data from Qualigen Therapeutics, Inc., you can adjust forecasts and instantly observe the results.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 5.6 4.3 5.7 5.0 5.2 5.2 5.2 5.3 5.3 5.3
Revenue Growth, % 0 -22.52 31.29 -11.85 4.44 0.33855 0.33855 0.33855 0.33855 0.33855
EBITDA -10.0 -11.2 -22.7 -13.8 -11.3 -5.2 -5.2 -5.3 -5.3 -5.3
EBITDA, % -180.31 -259.27 -400.85 -277.74 -217.12 -100 -100 -100 -100 -100
Depreciation .1 .1 .3 .0 .0 .1 .1 .1 .1 .1
Depreciation, % 2 3.22 5.7 0.2441 0.08636334 2.25 2.25 2.25 2.25 2.25
EBIT -10.1 -11.3 -23.0 -13.9 -11.3 -5.2 -5.2 -5.3 -5.3 -5.3
EBIT, % -182.32 -262.49 -406.55 -277.98 -217.2 -100 -100 -100 -100 -100
Total Cash .2 24.0 17.5 7.0 .4 3.2 3.3 3.3 3.3 3.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .7 .6 .8 .0 .0
Account Receivables, % 12.73 14.3 14.55 0 0
Inventories .7 1.0 1.1 1.6 .0 .9 .9 .9 .9 .9
Inventories, % 11.88 22.14 18.68 31.83 0 16.9 16.9 16.9 16.9 16.9
Accounts Payable .9 .5 .9 .6 2.2 1.0 1.0 1.0 1.0 1.0
Accounts Payable, % 15.82 11.63 15.68 12.43 42.71 19.65 19.65 19.65 19.65 19.65
Capital Expenditure -.2 -.2 -.1 -.3 .0 -.2 -.2 -.2 -.2 -.2
Capital Expenditure, % -3.5 -4.88 -2.5 -6.4 0 -3.46 -3.46 -3.46 -3.46 -3.46
Tax Rate, % -7.51 -7.51 -7.51 -7.51 -7.51 -7.51 -7.51 -7.51 -7.51 -7.51
EBITAT -10.2 -11.3 -23.0 -13.7 -12.2 -5.2 -5.2 -5.2 -5.3 -5.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -10.7 -12.0 -22.7 -14.0 -9.0 -7.8 -5.3 -5.3 -5.3 -5.3
WACC, % 11.73 11.73 11.73 11.65 11.73 11.71 11.71 11.71 11.71 11.71
PV UFCF
SUM PV UFCF -21.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -5
Terminal Value -56
Present Terminal Value -32
Enterprise Value -54
Net Debt 1
Equity Value -55
Diluted Shares Outstanding, MM 5
Equity Value Per Share -10.78

What You Will Get

  • Editable Forecast Inputs: Easily adjust key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Qualigen Therapeutics, Inc.’s (QLGN) financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A sleek Excel model tailored to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.

Key Features

  • Customizable Research Parameters: Adjust essential inputs such as clinical trial success rates, market penetration, and R&D expenditures.
  • Instant Valuation Metrics: Quickly computes intrinsic value, NPV, and additional financial outputs.
  • High-Precision Accuracy: Relies on Qualigen Therapeutics' actual financial data for realistic valuation results.
  • Effortless Scenario Analysis: Evaluate various assumptions and assess outcomes with ease.
  • Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Qualigen Therapeutics data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Qualigen Therapeutics’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Qualigen Therapeutics, Inc. (QLGN)?

  • User-Friendly Interface: Perfect for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters easily to suit your specific analysis needs.
  • Real-Time Feedback: Instantly view changes to Qualigen’s valuation as you tweak inputs.
  • Preloaded Data: Comes with Qualigen’s current financial metrics for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for sound decision-making.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for assessing investment opportunities in the biotech sector.
  • Corporate Development Teams: Evaluate valuation scenarios to inform strategic decisions and partnerships.
  • Consultants and Advisors: Deliver precise valuation insights for Qualigen Therapeutics, Inc. (QLGN) to clients.
  • Students and Educators: Utilize current data to practice and teach financial modeling in the biotech industry.
  • Biotech Enthusiasts: Gain insights into how companies like Qualigen Therapeutics, Inc. (QLGN) are valued within the market.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Qualigen Therapeutics historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Qualigen Therapeutics, Inc. (QLGN).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.